
Greenwich LifeSciences, Inc.
GLSI institutional ownership changes in Q2 2026: 25 institutions opened or added positions, 20 trimmed or exited. GLSI (Greenwich LifeSciences, Inc.) is held by 43 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($11.4M), Vanguard Capital Management LLC ($6.5M), Geode Capital Management, LLC ($3.9M). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Jul 30, 2026 · Activists none · Congress none
Top Holders
Showing 1-20 of 51
| Insider | Trade | Traded |
|---|---|---|
| Patel Snehal | Buy $9K | |
| Patel Snehal | Buy $20K | |
| Patel Snehal | Buy $20K | |
| Patel Snehal | Buy $14K | |
| Patel Snehal | Buy $33K | |
| Patel Snehal | Buy $54K | |
| Patel Snehal | Buy $80K | |
| Patel Snehal | Buy $52K | |
| Patel Snehal | Buy $39K | |
| Patel Snehal | Buy $89K |
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about GLSI
Who owns GLSI?
43 institutional investors held GLSI on June 30, 2026, led by BlackRock, Inc. ($11.4M), Vanguard Capital Management LLC ($6.5M) and Geode Capital Management, LLC ($3.9M).
How many hedge funds hold GLSI?
43 institutional investors reported GLSI in their 13F filings for the quarter ended June 30, 2026, $38.7M in all. 3 of them are rated Elite.
Are institutions buying or selling GLSI?
Buying, on balance. In Q2 2026, 25 institutions opened or added to positions in GLSI and 20 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer